Mirabel: an integrated project for risk and cost/benefit analysis of peanut allergy

Amélie Crépet (), Alexandra Papadopoulos (), Fabrice Elegbede, S Ait-Dahmane, C. Loynet, Guy Millet, X van Der Brempt, O Bruyère, Stéphan Marette () and D.A. Moneret-Vautrin
Additional contact information
Amélie Crépet: ANSES - Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
Alexandra Papadopoulos: ANSES - Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
Fabrice Elegbede: ANSES - Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
S Ait-Dahmane: ANSES - Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
C. Loynet: ANSES - Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
Guy Millet: ECO-PUB - Economie Publique - INRA - Institut National de la Recherche Agronomique - AgroParisTech
X van Der Brempt: Clinic Saint-Luc, Bouge, Namur
O Bruyère: ULiège - Université de Liège = University of Liège = Universiteit van Luik = Universität Lüttich
D.A. Moneret-Vautrin: Faculté de Médecine [Nancy] - UL - Université de Lorraine

Post-Print from HAL

Abstract: Food allergy is a major public health issue. However, no regulatory measures exist when allergens are present at trace levels and the different risk components are poorly described. Thus, knowledge on exposure components such as the allergens present in foods and the consumption behaviour of allergic consumers and models to estimate the related risk need to be enriched. Mirabel proposes for the first time studying each risk component using an integrated approach in order to improve the quality of life of the allergic population. Field surveys were conducted in order to fill in the current gaps in unintentional allergen traces in food, allergic consumers' food behaviour, threshold doses of allergic reaction, allergy symptoms and severity. The aim is also to propose methodological and operational tools to quantify allergic risk, to test management scenarios and to produce a cost/benefit analysis. Medical data on the peanut allergies of 785 patients were collected in the MIRABEL survey and 443 patients answered the food consumption questionnaire. The population surveyed was mostly paediatric - 86% were children under 16 years of age, with a high percentage of males (60%). This project will generate tangible results on peanut allergen exposure and risk which could be used in future risk assessment work and particularly to provide science-based guidance to set up concentration limits for peanut traces on packages

Keywords: allergie alimentaire; analyse coût bénéfices; arachide; Allergic consumer behaviors; Allergy; Food labelling; Peanut allergen; Risk assessment; Risk management (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

Published in Regulatory Toxicology and Pharmacology, 2015, 71 (2), pp.178-183. ⟨10.1016/j.yrtph.2014.12.006⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01173057

DOI: 10.1016/j.yrtph.2014.12.006

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().